D002243Chemicals & DrugsD03.383.725.150D03.633.100.473.155D03.633.300.154220.996884CarbolinesFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.4730520.1511812research area of0.474530.1516533subject area fortrue1ProfessorProfessorPsychiatryMarkPollackMark Pollack41.87724600000000-87.66843480000000349127Pollack, MarkProfessor4Professor9363044Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BGThe Journal of clinical psychiatryAbecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. J Clin Psychiatry. 1997; 58 Suppl 11:19-23.J Clin Psychiatry1997-01-01T00:00:001997Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.21762988Arif SA, Poon HClinical therapeuticsTadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension. Clin Ther. 2011 Aug; 33(8):993-1004.Clin Ther2011-07-16T00:00:002011Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension.Neurological SciencesRush University, Rush Medical CollegeDenisEvansDenis Evans41.87724600000000-87.66843480000000349006Evans, DenisProfessortrue1ProfessorProfessor23751159Bonazzi S, Cheng B, Wzorek JS, Evans DAJournal of the American Chemical SocietyTotal synthesis of (-)-nakadomarin A. J Am Chem Soc. 2013 Jun 26; 135(25):9338-41.J Am Chem Soc2013-06-17T00:00:002013Total synthesis of (-)-nakadomarin A.